These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9925191)

  • 41. Comparison of early and delayed inpatient dexamethasone suppression tests.
    Haskett RF; Zis AP; Albala AA; Lohr NE; Carroll BJ
    Psychiatry Res; 1989 Feb; 27(2):161-71. PubMed ID: 2710864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biological correlates of the Newcastle Scale in depressive illness: a multivariate approach.
    Staner L; Maes M; Bouillon E; Linkowski P
    Acta Psychiatr Scand; 1992 May; 85(5):345-50. PubMed ID: 1605054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response to dexamethasone in affective disorder outpatients.
    Steardo L; Cardone G; Casiello M; Sorge F; Muscettola G
    Acta Psychiatr Belg; 1984; 84(3):218-27. PubMed ID: 6485840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early morning awakening in unipolar depressives with higher levels of platelet MAO activity.
    Agren H; Oreland L
    Psychiatry Res; 1982 Oct; 7(2):245-54. PubMed ID: 6183704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The dexamethasone suppression test in psychotic disorders.
    Arana GW; Barreira PJ; Cohen BM; Lipinski JF; Fogelson D
    Am J Psychiatry; 1983 Nov; 140(11):1521-3. PubMed ID: 6625007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosis and subtyping of depressive disorders by quantitative electroencephalography: III. Discriminating unipolar from bipolar depression.
    Lieber AL; Newbury ND
    Hillside J Clin Psychiatry; 1988; 10(2):165-72. PubMed ID: 3147236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic heterogeneity and the DST in consecutive psychiatric admissions.
    Keitner GI; Haier RJ; Qualls CB; Brown WA; McKendall MJ
    Psychiatry Res; 1985 Mar; 14(3):215-23. PubMed ID: 3858894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects.
    Rubin RT; Heist EK; McGeoy SS; Hanada K; Lesser IM
    Arch Gen Psychiatry; 1992 Jul; 49(7):558-67. PubMed ID: 1627047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the ACTH suppression test and dexamethasone suppression test in depressed patients.
    Demisch K; Demisch L; Bochnik HJ; Schulz F
    Am J Psychiatry; 1983 Nov; 140(11):1511-2. PubMed ID: 6312817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet monoamine oxidase activity and clomipramine-induced mania in unipolar depressed patients.
    van Kammen DP; van Scheyen JD; Murphy DL
    Biol Psychiatry; 1980 Aug; 15(4):565-73. PubMed ID: 7397287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melatonin suppression by light in euthymic bipolar and unipolar patients.
    Nurnberger JI; Adkins S; Lahiri DK; Mayeda A; Hu K; Lewy A; Miller A; Bowman ES; Miller MJ; Rau L; Smiley C; Davis-Singh D
    Arch Gen Psychiatry; 2000 Jun; 57(6):572-9. PubMed ID: 10839335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet monoamine oxidase activity in elderly depressed outpatients.
    Schneider LS; Severson JA; Pollock V; Cowan RP; Sloane RB
    Biol Psychiatry; 1986 Dec; 21(14):1360-4. PubMed ID: 3790624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroendocrine measures in psychiatric patients: course and outcome with ECT.
    Papakostas Y; Fink M; Lee J; Irwin P; Johnson L
    Psychiatry Res; 1981 Feb; 4(1):55-64. PubMed ID: 6784139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The dexamethasone suppression test in outpatients with primary affective disorder and healthy control subjects.
    Amsterdam JD; Winokur A; Caroff SN; Conn J
    Am J Psychiatry; 1982 Mar; 139(3):287-91. PubMed ID: 7058940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biological markers of melancholia and reclassification of depressive disorders.
    Greden JF
    Encephale; 1982; 8(2):193-202. PubMed ID: 6809444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
    Targum SD
    Biol Psychiatry; 1983 Jan; 18(1):3-19. PubMed ID: 6403062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The diagnoses of schizophrenia, schizoaffective disorder, bipolar disorder and unipolar depression: interrater reliability and congruence between DSM-IV and ICD-10.
    Cheniaux E; Landeira-Fernandez J; Versiani M
    Psychopathology; 2009; 42(5):293-8. PubMed ID: 19609099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dexamethasone suppression test in a pluridiagnostic approach: its relationship to psychopathological and clinical variables.
    Kasper S; Beckmann H
    Acta Psychiatr Scand; 1983 Jul; 68(1):31-7. PubMed ID: 6613617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The noncompliance factor in the dexamethasone suppression test.
    Remillard AJ; O'Reilly R; Gorecki DK; Blackshaw SL; Quinn D; Keegan DL
    Biol Psychiatry; 1993 May; 33(10):755-6. PubMed ID: 8353173
    [No Abstract]   [Full Text] [Related]  

  • 60. Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings.
    Rush AJ; Schlesser MA; Roffwarg HP; Giles DE; Orsulak PJ; Fairchild C
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):23-9. PubMed ID: 6409892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.